ABB – inadequate Governance – $100 million internal fraud
Swiss engineering group ABB (ABBN.S) on Wednesday said it fell victim to a “sophisticated criminal scheme” at its South Korean subsidiary, with the ... »
-
-
-
-
-
-
-
-
-
-
Slide #23
-
Slide #24
-
-
Latest Articles
FT LEX – Zurich: bland ambition
Simplicity may be a virtue to new Zurich Insurance boss Mario Greco; ambition certainly is not. On Thursday the CEO, who joined from Generali in March, branded ... »
Novartis’ ‘breakthrough’ muscle drug bimagrumab flunks a late-stage trial
Novartis ($NVS) buried some bad pipeline news in its quarterly report today. The pharma giant says that its “breakthrough” drug bimagrumab (BYM338) failed a Pha... »
SIX Swiss Exchange wins “Exchange of the Year” award at the Structured Products Awards Europe 2016.
The Structured Products Europe awards have an excellent reputation in the industry. They were introduced to recognize the best European financial service provid... »
Novartis Is Struggling To Compete
Nov. 2, 2015 Summary: Novartis has seen its operations deteriorate in recent years. Both margins and top-line growth have contracted in 2015. With rising compet... »
Swiss Exchange – Morning / Evening Report
Daily market preview and market wrap up from a leading swiss finance newspaper "Finanz & Wirtschaft" (in German) »
